Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FREELINE THERAPEUTICS HOLDINGS PLC

(FRLN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Freeline Therapeutics : Files for Up to $250 Million Mixed-Securities Shelf

09/13/2021 | 05:37am EDT


© MT Newswires 2021
All news about FREELINE THERAPEUTICS HOLDINGS PLC
10/19FREELINE THERAPEUTICS : Morgan Stanley Adjusts Freeline Therapeutics Holdings' Price Targe..
MT
09/20FREELINE THERAPEUTICS HOLDINGS PLC(N : FRLN) dropped from S&P Global BMI Index
CI
09/13FREELINE THERAPEUTICS : Files for Up to $250 Million Mixed-Securities Shelf
MT
09/09FREELINE THERAPEUTICS' : FLT201 Receives Orphan Drug Designations in US, EU
MT
09/09FREELINE THERAPEUTICS : Announces Orphan Drug Designations for FLT201 for the Treatment of..
AQ
09/07FREELINE THERAPEUTICS : to Participate in Upcoming Investor Conferences in September 2021
AQ
08/18FREELINE THERAPEUTICS : HC Wainwright Adjusts Price Target on Freeline Therapeutics Holdin..
MT
08/17FREELINE THERAPEUTICS : JPMorgan Downgrades Freeline Therapeutics Holdings to Neutral From..
MT
08/16FREELINE THERAPEUTICS : Wedbush Adjusts Price Target for Freeline Therapeutics Holdings to..
MT
08/16Freeline Therapeutics Holdings plc Announces Chief Executive Officer Changes
CI
More news
Analyst Recommendations on FREELINE THERAPEUTICS HOLDINGS PLC
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -136 M - -
Net cash 2021 170 M - -
P/E ratio 2021 -0,87x
Yield 2021 -
Capitalization 113 M 113 M -
EV / Sales 2021 -
EV / Sales 2022 -
Nbr of Employees 236
Free-Float 97,0%
Chart FREELINE THERAPEUTICS HOLDINGS PLC
Duration : Period :
Freeline Therapeutics Holdings plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FREELINE THERAPEUTICS HOLDINGS PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 3,15 $
Average target price 12,63 $
Spread / Average Target 301%
EPS Revisions
Managers and Directors
Michael J. Parini Chief Executive Officer & Director
Christopher John Hollowood Chairman
Amit Chunilal Nathwani Independent Director & Chief Scientific Officer
Markus Hörer Chief Technology Officer
James Bircher Chief Technical Operations Officer
Sector and Competitors
1st jan.Capi. (M$)
FREELINE THERAPEUTICS HOLDINGS PLC-82.75%113
GILEAD SCIENCES, INC.15.41%84 306
BIONTECH SE241.44%67 225
WUXI APPTEC CO., LTD.24.51%64 578
REGENERON PHARMACEUTICALS18.47%59 507
VERTEX PHARMACEUTICALS-22.35%47 610